King Pharmaceuticals News

Main Category: Pain / Anesthetics Also Included In: Pharma Industry / Biotech Industry Clinical Trials / Drug Trials King Pharmaceuticals, Inc.

Teva Pharmaceutical Industries Ltd., which bought Barr Laboratories Inc. for $7.4 billion last year, is ready for another "major" acquisition and may look beyond generic drugs for the purchase, Chief Executive Officer Shlomo Yanai said.

MOSCOW-- --Wimm-Bill-Dann Foods OJSC [NYSE: WBD] today announced its financial results for the quarter ended March 31, 2009.

REDWOOD CITY, Calif.-- --Trion World Network, Inc. , the publisher and developer of server-based video games, today revealed details of its first title, the highly anticipated fantasy Massively - 06/01/2009 - 08:56 AM Falcon Celebrates Environment Week NEW DELHI-- --Your planet needs you -- unite to combat climate change, Falcon Realty Services ...

King Pharmaceuticals, Inc. today announced the appointment of John J. Howarth to Vice President, Investor Relations.

He said, "Over the past 72 hours, I have become concerned that the developing tone and direction of the race for chairman will negatively impact the party." Mr.

As fundamentals-focused long-term investors, Fools never base an investment decision on the daily gyrations of the market.

Dr. Kenneth C. Hill of Blountville, who runs a Christian radio station and is a member of the state Republican Executive Committee, has been named to serve as a Tennessee Regulatory Authority director by Lt.

King Pharmaceuticals posted a net loss of $11 million, a diluted loss per share of four cents for the first quarter of 2009, versus a gain of 35 cents per share a year ago.

Drug stocks traded in the doldrums early Monday while shares of AstraZeneca PLC and King Pharmaceuticals gained ground.

Ron Ramsey: Whatever it takes! The latest evidence that Ron Ramsey will do anything to win the Republican gubernatorial primary: He's appointing Dr.

SAN DIEGO,A Calif. King Pharmaceuticals will present study findings from its expanded pain management portfolio at the American Pain Societya s Annual Meeting, the company announced Thursday.

BRISTOL, Tenn.-- --King Pharmaceuticals, Inc. today announced plans to provide a live webcast of its presentation scheduled for Tuesday, May 12, 2009, at 2:00 p.m. ET at the Bank of America and - PALO ALTO, Calif.-- --HP : - ATLANTA-- --SunLink Health Systems, Inc.

The Annual Junior Achievement Hall of Fame dinner Friday night honored two community leaders.

May 1, 2009 - King Pharmaceuticals, Inc. and Acura Pharmaceuticals, Inc. today presented the results from an oral abuse liability study of Acurox Tablets, AP-ADF-111 , at the American Society of Addiction Medicine's Medical-Scientific Conference.

King Pharmaceuticals Inc. in 2008 paid its chief executive a little more than half his compensation from the previous year, largely because of a decline in stock and options awards, according to an Associated Press analysis of a regulatory filing.

A ruptured natural gas line forced the evacuation Thursday afternoon of King Pharmaceuticals.

Shares of Bristol, Tenn.-based King Pharmaceuticals Inc. rose Wednesday after a Goldman Sachs analyst put the stock on a recommended list, saying King's pain drug Embeda could be approved for sale very soon.

Shares of F5 Networks Inc. climbed on Wednesday, after the company disclosed that second-quarter earnings would be higher than expected as cost cuts and a share buyback boosted profits despite a slowdown in sales.

Analyst Choice has combined some of the best financial and technical minds worldwide to bring you an array of free quality equity research and reporting.